Screener
Opus Genetics IRD Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $88.91M+174% | $59.96M+43.5% | $45.09M+48.7% | $30.82M-15.9% | $32.43M-21.7% | ||
| $1.04M-69.4% | $1.73M-43.8% | $2M-44.0% | $2.92M+57.0% | $3.4M+150% | ||
| $92.7M+141% | $66.6M+39.0% | $50.04M+36.7% | $35.91M-11.1% | $38.44M-14.3% | ||
| $172K-23.9% | $186K-22.2% | $199K-21.0% | $212K— | $226K— | ||
| $92.97M+140% | $66.79M+38.7% | $50.24M+36.3% | $36.12M-10.6% | $38.67M-13.8% | ||
| $1.88M+28.4% | $4.42M+82.0% | $3.29M+4.6% | $2.4M+184% | $1.47M+131% | ||
| $7.61M-62.3% | $9.34M-61.5% | $7.78M-31.1% | $29.09M+378% | $20.19M+381% | ||
| $35.28M+3,428% | $1.2M— | $1.13M— | $1.07M— | $1M— | ||
| $97.08M+358% | $77.35M+219% | $25.99M+130% | $30.16M+395% | $21.19M+405% | ||
| 250M+100% | 125M0.0% | 125M+4,166,567% | 125M0.0% | 125M+66.7% | ||
| -$262.22M-69.6% | -$254.12M-72.6% | -$188.59M-35.7% | -$172.07M-65.7% | -$154.61M-60.5% | ||
| -$12.99M-174% | -$45.84M-1,004% | $15.35M+128% | $5.97M-82.6% | $17.47M-57.0% | ||
| $92.97M+140% | $66.79M+38.7% | $50.24M+36.3% | $36.12M-10.6% | $38.67M-13.8% |
FAQ
- What are Opus Genetics's total assets?
- Opus Genetics (IRD) holds $93.0M in total assets, up 140.4% year over year.
- How much debt does Opus Genetics have?
- Opus Genetics carries $35.3M in total debt against -$13.0M of shareholders' equity, a debt-to-equity ratio of 0.07.
- How much cash does Opus Genetics have?
- Opus Genetics holds $88.9M in cash and equivalents.
- Can Opus Genetics cover its short-term obligations?
- Its current ratio is 12.19 — current assets exceed current liabilities.
- Where does Opus Genetics's balance sheet data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
